ABSTRACT
INTRODUCTION I
N THE UNITED STATES, nearly half of all pregnancies are unplanned, leading to 3.1 million unintended pregnancies and 1.3 million abortions annually. 1, 2 The highest rates of unintended pregnancy occur in college-age women, with 60% of pregnancies among 20-24-year-olds being unintended. 1 The percentage of unintended pregnancy is even higher among 18-19-year-old women (79%). 1 Emergency contraception (EC) is a safe and effective postcoital contraceptive method that can reduce the risk of an unintended pregnancy after unprotected sexual intercourse or contraceptive failure by at least 75%-89% if taken within 72 hours of sexual intercourse. [3] [4] [5] Recent research suggests that combined EC pills are moderately effective even if started between the third and fifth days (up to 120 hours) after unprotected sexual intercourse or contraceptive failure, with effectiveness rates ranging from 72% to 87% in one study. 6, 7 EC may operate by inhibiting ovulation or preventing the implantation of a fertilized egg; however, it does not interfere with an established pregnancy. 8 15 It remains prescription-only for minors.
As there is a dearth of published information about individuals' opinions regarding advance provision and OTC access to EC, a study exploring such avenues among an at-risk population prior to the FDA decision was both timely and appropriate. In doing so, this research built on the recent work by Sawyer and Thompson 16 and Corbett et al. 17 that assessed EC knowledge of university students. The purpose of this study was to assess college students' perceptions about EC provision and, in particular, their knowledge of and opinions about OTC access, including whether OTC availability of EC might change their personal birth control practices.
MATERIALS AND METHODS
The University of Michigan Medical School's Institutional Review Board approved this study. A waiver of documentation of informed consent was granted by the Institutional Review Board, and text regarding the consent process was included in the initial e-mail to students. A random sample of 7000 students (both undergraduate and graduate level; 20% of all students) enrolled fulltime at the University of Michigan during the winter 2006 semester (January-April 2006) was drawn by the University's Office of the Registrar, who sent an e-mail on our behalf to invite students to participate in a web-based survey through SurveyMonkey (www.surveymonkey.com) in April 2006. A reminder e-mail was sent to all 7000 students 1 week later. No financial incentive was offered. We analyzed data from 1585 college students who completed the survey within a 30-day period (response rate 22.6%). The survey system was programmed to allow only one response per person.
The survey instrument included questions about the respondents' knowledge of and beliefs about EC provision. It was estimated to take 5-10 minutes to complete. Background information about EC, such as what it was, how it worked, and time frame for taking it, was provided to all respondents prior to the first question. Next, respondents were asked to complete 11 multiple choice questions about their knowledge of and access to EC. Specific items asked about how they first learned of EC, whether they believed it should be used in cases of rape, contraceptive failure, or unprotected sexual intercourse, respectively, and advance provision. Questions on how the respondents first learned about EC and in what cases EC should be used were adapted from a 2003 Kaiser Family Foundation (KFF) Survey. 18 Respondents were provided with information about the current status of EC provision in Michigan and the potential for OTC access. Four multiple choice questions asked respondents about their awareness of the debate about OTC access, whether they believed that it should be available OTC, and whether OTC availability of EC might change their personal birth control practices. For female respondents, we also inquired about their current interaction with the healthcare system and whether they received information about or a supply of EC in advance of need as part of these visits. The survey concluded with a series of questions to ascertain demographic information about the study population (e.g., age, gender, race and Hispanic origin classification, undergraduate/ graduate status). The survey instrument was pilot tested among a small convenience sample of students and family planning providers, who provided suggestions for refining the instrument that were incorporated into the final version. A copy of the survey instrument is provided in the Appendix. No personal identifying information was collected; thus, individual responses were anonymous.
Frequencies were calculated for all items, and comparisons were made between male and female respondents and by age (17-22 years vs. 23-51 years) about their attitudes toward EC provision. Chi-square tests and Student's t tests were performed where appropriate to test for statistical significance (p Ͻ 0.05). Statistical Analysis Software (SAS) version 9.1 (SAS Institute Inc., Cary, NC) was used for all analyses. Table 1 describes the characteristics of our study population. The average age of our respondents was 22.5 years. Sixty-six percent of respondents were female, and 60% were undergraduates. The race and Hispanic origin composition of our study population was representative of the broader University of Michigan student population.
RESULTS
Nearly all respondents (94%) said that they had heard of EC prior to receiving the survey. However, 12% indicated that they did not know the longest time window for effectiveness, and 45% of respondents stated that EC must be taken within 3 days or 72 hours after unprotected sexual intercourse or contraceptive failure. Only 5% responded that EC must be taken within 5 days or 120 hours (shown in research studies 6, 7, 19 to be the longest time window in which EC can be effective). Respondents first learned of EC from a variety of sources, including the media (43%), friends or peers (22%), and school-based curriculum (18%). When students were asked what would be the most effective way to inform their peers and the public about EC, a similar response was given, with 14% of respondents also indicating healthcare providers as a source of information. Nearly three fourths of respondents believed that students were aware of EC as an option. and by sex and age. Ninety-three percent of respondents approved of the use of EC in the case a woman was raped. Eighty-six percent approved of its use in the instance of contraceptive failure, but only 68% approved of its use after unprotected sexual intercourse. Female and older students were more likely to approve of the use of EC in each instance, compared with male and younger students, respectively. Results stratified by the respondent's sex were statistically significant for questions about the instance of rape and contraceptive failure, whereas those stratified by the respondent's age were statistically significant for questions about the instance of contraceptive failure and unprotected sexual intercourse and marginally significant in the instance of rape. Table 3 summarizes the knowledge and opinions of college students about the federal gov- ernment's plans to make EC available OTC. Only 57% of respondents indicated that they were aware of this policy debate prior to receiving the survey. A significantly higher proportion of women and older students were aware of the debate, in comparison to men and younger students, respectively. More than half of respondents (60%) believed that EC should be available OTC. However, nearly one quarter (23%) disagreed, and 17% were unsure. When asked what they would do if EC was available OTC, 33% of respondents indicated that they would purchase a supply in advance of need, and 44% responded that they would purchase a supply after unprotected sex. Nineteen percent of respondents stated that they would not purchase EC. Overall, only 10% of all female respondents indicated that their current healthcare provider had spoken to them about EC in a routine visit, and just 5% of female respondents were offered a supply in advance of need. Nearly 1 in 4 female respondents indicated that they do not currently receive routine gynecological care. Among the 346 female respondents who responded that they would purchase a supply in advance of need if EC were to become available OTC, only 15% indicated that their healthcare provider had spoken to them about it during a routine office visit, and approximately 7% were offered a supply in advance of need.
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DISCUSSION
Although EC is now available OTC to individuals aged Ն18 years, there remains a critical need for continued health education about EC. Previous studies on EC knowledge and use show that although the general public and university students have heard of EC, they generally lack sufficient knowledge about what it is, how it works, and how to access it. [16] [17] [18] 20 Our findings are comparable to this body of research. Whereas OTC availability of EC may allow for increased access, its success is linked to the dissemination of accurate information about EC via trusted informational sources, such as family, friends, healthcare providers, and the media. One challenge in educating college students and other young adults about EC is the identified lack of information about EC shared by healthcare providers with this population. The challenge to healthcare providers is to increase awareness and use of such preventive services. 21, 22 Although increasing the number of women who take postcoital contraception is not likely to reduce risky sexual behaviors, it may reduce the number of unwanted pregnancies and abortions that occur each year in the United States.
Our findings on awareness and knowledge about EC are comparable to those of other studies that included a college student population. 16, 17 Sawyer and Thompson 16 reported that nearly 86% of their undergraduate respondents stated that they had heard about EC, but the majority indicated that their perceived knowledge was low. Similarly, Corbett et al. 17 indicated that 96% of respondents (college students aged 18-21 years) stated that they had heard about EC, but only 18% had previously discussed EC with their healthcare provider. 17 Our findings regarding gender differences in EC decision making were different from those presented by Corbett et al., 17 who reported that 67% of their female respondents and only 46% of their male respondents stated that they would be likely to use (or recommend) EC in the event of contraceptive failure. In our study, whereas female respondents (88%) were more likely than male respondents (82%) to approve of the use of EC in the event of contraceptive failure, 86% of respondents overall approved of its use in this instance.
There were some limitations to this study that may limit the validity of our findings. The results of our study are dependent on the accuracy of our participants' responses. Our study population consisted of a random sample of students who were enrolled full-time at the University of Michigan. Thus, our findings may not reflect the opinions of all U.S. college students. Our survey response rate (22.6%) was lower than anticipated. As information on nonresponders was not available to the research team, we can only speculate as to why some students chose not to respond to the survey. Such factors as the timing of survey administration (a few weeks prior to the end of the semester), the subject matter of the survey, and the lack of an incentive may have contributed to the response rate we achieved.
CONCLUSIONS
Advance discussion and provision of EC is underused. Because of the higher risk for an un-
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planned pregnancy with unprotected sexual intercourse or contraceptive failure among college women, continued efforts are needed to enhance timely access to EC in this population. Findings from this study suggest that there are multiple avenues from which to educate young adults about EC. Healthcare providers and health educators would be invaluable resources for informing campus communities about EC and its OTC availability and for reinforcing ongoing health communication campaigns in the popular press.
